Company November Pharma S.r.l. with Fiscal Code 46194592
recorded a turnover of 2024 of
27.235,
with a net profit of
6.342
and having an average number of employees of
1.
The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
November Pharma S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
-
-
-
14.812
25.312
27.235
Total Income - EUR
-
-
-
-
-
-
-
14.812
25.312
27.235
Total Expenses - EUR
-
-
-
-
-
-
-
3.589
12.193
20.621
Gross Profit/Loss - EUR
-
-
-
-
-
-
-
11.222
13.119
6.615
Net Profit/Loss - EUR
-
-
-
-
-
-
-
11.044
12.866
6.342
Employees
-
-
-
-
-
-
-
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 8.2%, from 25.312 euro in the year 2023, to 27.235 euro in 2024.
The Net Profit decreased by -6.452 euro, from 12.866 euro in 2023, to 6.342 in the last year.
Check the financial reports for the company - November Pharma S.r.l.
Financial Rating - NOVEMBER PHARMA S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - November Pharma S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - November Pharma S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - November Pharma S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
November Pharma S.r.l. - CUI 46194592
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
-
-
-
0
0
533
Current Assets
-
-
-
-
-
-
-
11.740
13.545
19.024
Inventories
-
-
-
-
-
-
-
0
0
0
Receivables
-
-
-
-
-
-
-
1.588
3.736
2.010
Cash
-
-
-
-
-
-
-
10.152
9.809
17.014
Shareholders Funds
-
-
-
-
-
-
-
11.084
12.907
19.177
Social Capital
-
-
-
-
-
-
-
41
40
40
Debts
-
-
-
-
-
-
-
656
638
380
Income in Advance
-
-
-
-
-
-
-
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4619 - 4619"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
19.024 euro in 2024 which includes Inventories of
0 euro, Receivables of
2.010 euro and cash availability of
17.014 euro.
The company's Equity was valued at
19.177 euro, while total Liabilities amounted to
380 euro.
Equity increased by 6.342 euro, from 12.907 euro in 2023, to 19.177 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - November Pharma S.r.l.